Reagan-Udall reports mean different strokes for different arms of US FDA

The Reagan-Udall Foundation’s reports on the US Food and Drug Administration (FDA) provide “substantially different future policy implications” for the different FDA programs investigated, according to a lawyer specialising in FDA regulation.

The report on the FDA’s Human Foods Program emphasises specifics for the agency’s organisational structure unlike the recommendations in the report on the FDA’s Center for Tobacco Products (CTP), which has a more operational focus, urging a more proactive approach to enforcement, attorney Joshua Ari Van De Riet told ECigIntelligence.

Read full article
I'm already a subscriber
Author default picture


This article was written by one of ECigIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual vaping markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization